4.7 Article

Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2022.02.026

关键词

Lipids; asthma; nasal airway epithelium; proresolving lipids; oxylipins; resolvins; PUFAs; EPA; DHA; AA

资金

  1. National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute (NHLBI) [R01HL104608]
  2. NIH-National Center for Research Resources [1S10OD010366-01A1]
  3. NIH-NHLBI [R01HL123385]
  4. Programa de Apoio a Nucleos Emergentes (PRONEM)-Fundacao de Amparoa Pesquisa do Estado da Bahia (FAPESB) [009/2014, PNE0003/2014, 8305/2014]

向作者/读者索取更多资源

By analyzing nasal epithelial samples, we found that lipid mediators are detectable and can distinguish asthma cases from control subjects, suggesting their potential involvement in the pathogenesis of asthma.
Background: Lipid mediators, bioactive products of polyunsaturated fatty acid metabolism, contribute to inflammation initiation and resolution in allergic diseases; however, their presence in lung-related biosamples has not been fully described. Objective: We aimed to quantify lipid mediators in the nasal airway epithelium and characterize preliminary associations with asthma. Methods: Using liquid chromatography-mass spectrometry, we conducted a pilot study to quantify 56 lipid mediators from nasal epithelial samples collected from 11 female participants of an outpatient asthma clinic and community controls (aged 30-55 years). We examined the presence of each compound using descriptive statistics to test whether lipid mediators could distinguish subjects with asthma (n = 8) from control subjects (n = 3) using linear regression and partial least squares discriminant analysis. Results: Fifteen lipid mediators were detectable in all samples, including resolvin (Rv) D5 (RvDS), with the highest median concentrations (in pg/mu g protein) of 13-HODE (126.481), 15-HETE (32.869), and 13-OxoODE (13.251). From linear regression adjusted for age, prostaglandin E-2 (PGE2) had a trend (P < .1) for higher concentrations in patients with severe asthma compared to controls (mean difference, 0.95; 95% confidence interval, -0.04 to 1.95). Asthma patients had higher scores on principal component 3 compared to controls (mean difference, 2.42; 95% confidence interval, 0.89 to 3.96), which represented lower levels of proresolving 15-HEPE, 19,20-DiHDPA, RvDS, 14-HDHA, 17-HDHA, and 13-HOTrE. Most of these compounds were best at discriminating asthma cases from controls in partial least squares discriminant analysis. Conclusion: Lipid mediators are detectable in the nasal epithelium, and their levels distinguish asthma cases from controls.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据